Total raised
$33.2M
Last: Undisclosed 2024-10
Stage
Seed
Founded
2014
Headcount
11
HQ
Netanya
Sector
Health Tech & Life Sciences
About
Vensica is developing ViXe, a product that combines Xeomin, a commercial neurotoxin, and Vibe, a breakthrough, needle-free, ultrasound drug delivery device.
Vibe is a breakthrough platform designed to deliver drugs directly into the bladder wall, providing uniform, controlled and localized treatments for urology applications. Vibe leverages a disruptive ultrasound technology to deliver drugs through the natural barriers of the urinary bladder. By generating cavitation bubbles, Vibe precisely microinjects the drugs into the bladder wall, ensuring a controlled and uniform delivery of medications and biologics.
Funding history · 6 rounds · $33.2M total
2024-10
Undisclosed
$11.0M
2022-02
Undisclosed
$3.0M
2021-11
Undisclosed
$16.0M
2017-09
Undisclosed
$2.0M
2016-07
Seed
$500K
2014-08
Seed
$700K
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Vensica Medical's primary product and its function?
- Vensica Medical is developing ViXe, a product that combines Xeomin, a commercial neurotoxin, and Vibe, a needle-free, ultrasound drug delivery device. Vibe is designed to deliver drugs directly into the bladder wall for urology applications.
- When was Vensica Medical founded and where is its headquarters located?
- Vensica Medical was founded in August 2014 and its headquarters is located in Netanya, Israel.
- What was Vensica Medical's initial funding round and who was a lead investor?
- In August 2014, Vensica Medical secured a Seed funding round of $700,000. The Trendlines Group was an investor in this round.
- Which strategic partner invested in Vensica Medical in February 2022?
- In February 2022, Merz Therapeutics invested in Vensica Medical as part of an undisclosed funding round totaling $3,000,000.
- What was the most recent funding round for Vensica Medical and its purpose?
- In October 2024, Vensica Medical secured an $11 million funding round, led by Israel Biotech Fund, to support Phase 2 trials for overactive bladder treatment.
- How many employees does Vensica Medical currently have?
- Vensica Medical currently has 11 employees.
- What is Vensica Medical's total amount raised in funding to date?
- Vensica Medical has raised a total of $33,200,000 in funding to date. For a full financing history, refer to startupim.
- Which company made a $2 million investment in Vensica Medical in September 2017?
- In September 2017, Cogentix Medical made a $2 million investment in Vensica Medical, as a lead investor, for its device for drug delivery to the bladder.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Simulation & ImagingUltrasound
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
hospitalscancerdrug-deliverymedical-devicesurinary-systemcathetersultrasoundoncologyurologyminimally-invasivepain-freetreatmentsbioconvergence